Some of the names on the move ahead of the open.
Anthem’s CEO Joe Swedish on the exchanges under the ACA and what it will mean if the deal isn't allowed to go forward.
Anthem’s CEO Joe Swedish discusses the facts that did not get considered regarding its battle against the Justice Department and estimates a four-month trial.
The Justice Department files suits to block two megadeals in the health insurance industry, saying they would harm competition across the country.
CNBC's David Faber discusses the Justice Department's lawsuits to block two major health insurer mergers.
DOJ files a lawsuit to block the Aetna-Humana merger. Mark Bertolini, Aetna chairman and CEO, discusses Aetna's side of the story.
Bill Baer, Justice Department Antitrust Chief, announces two separate lawsuits against health insurance mergers.
The Department of Justice is filing lawsuits to oppose both the Aetna-Humana merger, and the Anthem-Cigna deal, reports CNBC's Bertha Coombs.
Washington regulators are scuttling deals like it’s nobody’s business. Perhaps, it isn’t.
CNBC's David Faber reports the Department of Justice has filed lawsuits to block health insurance mergers.
The Department of Justice is filing a lawsuit to block the Anthem-Cigna deal, reports CNBC's David Faber.
Aetna and Humana are prepared to fight in court if the Department of Justice blocks their deal.
Shares of Anthem, Cigna, Aetna and Humana fell after the DOJ is expected to file lawsuits to block their acquisition deals.
The Justice Department is nearing a decision on Aetna's $34 billion deal with Humana and Anthem's $54 billion agreement to buy Cigna.
Shares of Humana dived more than 10 percent after speculation from analysts that the DOJ wants to meet over antitrust concerns.
The "Fast Money" traders give their final trades of the day.
CNBC's "Fast Money" traders threw traditional safety trades out the window on Wednesday.
The "Fast Money" traders share their final trades of the day.
If regulators block Anthem's merger with Cigna, the insurance companies may be better off just walking away, analysts said.
Stifel Nicolaus started coverage on Cigna with a buy rating and a $169 target on shares, based on the current Anthem deal value.